The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Sunnyvale.
The high activity for fund was in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Vives Fund, S.R.I.W., Nivelinvest.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium. We can highlight the next thriving fund investment areas, such as Biotechnology, Therapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Novadip Biosciences.
Fund Name | Location |
Bank Of Jiangsu | China, Jiangsu, Nanjing |
BBVA | Panamá, Panama, Panama City |
Beacon Funding | Illinois, Northbrook, United States |
Clear Ventures | California, Palo Alto, United States |
Cornel Capital Partners | Chicago, Illinois, United States |
Evergrande Health Industry Group | China, Guangdong, Guangzhou |
Fengjia Capital Management | Beijing, Beijing, China |
Ginserv | Bangalore, India, Karnataka |
Global Investment Banking | Dubai, United Arab Emirates |
Hopeshine Ventures | - |
Imanpreet | - |
MDVC | - |
Newton Biocapital | Belgium, Brussels, Brussels Hoofdstedelijk Gewest |
Pomona Impact | - |
Sands Capital Ventures | Arlington, United States, Virginia |
SLD Entertainment | Japan, Minato |
Startupbootcamp InsurTech London | England, London, United Kingdom |
The Chinese Founders Fund | Beijing, Beijing, China |
Umusun Lab | Japan, Okinawa, Okinawa Prefecture |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Novadip Biosciences | $33M | 10 Sep 2015 | Belgium, Walloon Brabant, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Novadip Biosciences | $33M | 10 Sep 2015 | Belgium, Walloon Brabant, Belgium |